Effect of Actonel on Periodontal Health of Postmenopausal Women

University Hospitals (UH)

Status and phase: Withdrawn; Phase 4

Conditions: Periodontal Disease

Treatments: Drug: Risedronate

Study type: Interventional

Funder types: Other

Identifiers

NCT00594334

010706

Details and patient eligibility

About

Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.

Full description

Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.

Sex: Female

Ages: 40 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Osteopenia
• Postmenopausal

Exclusion criteria

• Male
• Diabetes

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

0 participants in 1 patient group

E, I

Experimental group

Treatment:

Drug: Risedronate